Actinium Pharmaceuti
Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference
January 04, 2017 07:00 ET | Actinium Pharmaceuticals
NEW YORK, Jan. 04, 2017 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for...
Actinium Pharmaceuti
Actinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of Analytical Development to Support BLA and IND Enabling Analytical Studies for Current and Future Clinical Programs
December 19, 2016 07:00 ET | Actinium Pharmaceuticals
- Dr. Larrieux brings significant experience managing analytical development quality control of immunotherapies to treat cancer and small molecule therapies at pharmaceutical and biotechnology...
American Health Council Names Carlos Encarnacion, M.D. to Physician Board
American Health Council Names Carlos Encarnacion, M.D. to Physician Board
December 14, 2016 11:36 ET | American Health Council
NEW YORK, Dec. 14, 2016 (GLOBE NEWSWIRE) -- Dr. Carlos Encarnacion, Physician at Texas Oncology, has been selected to join the Physician Board at the American Health Council. He will be sharing...
Actinium Pharmaceuti
Actinium Pharmaceuticals Announces Submission of EU Orphan Designation Application for Actimab-A
December 13, 2016 07:00 ET | Actinium Pharmaceuticals
-  Actimab-A has received Orphan Drug Designation in the U.S. -  Orphan Designation in the EU can result in regulatory assistance, reduced fees and 10 years of market exclusivity ...
Actinium to Sponsor
Actinium to Sponsor Upcoming Blood & Marrow Transplant Information Network Webinar Focused on Stem Cell Transplants for Patients with AML
December 12, 2016 07:00 ET | Actinium Pharmaceuticals
Patient focused webinar titled “Stem Cell Transplants for Acute Myeloid Leukemia: What you Need to Know” Webinar to be led by transplant expert, Dr. Patrick Stiff, Director of the Cardinal...
American Health Council Names Julie Hammon, MSN, RN, OCN to Nursing Board
American Health Council Names Julie Hammon, MSN, RN, OCN to Nursing Board
December 08, 2016 12:03 ET | American Health Council
NEW YORK, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Julie Hammon, Oncology Nurse Navigator at Oaklawn Hospital in Michigan, has been selected to join the Nursing Board at the American Health Council....
Actinium Highlights
Actinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual Meeting
December 05, 2016 21:00 ET | Actinium Pharmaceuticals
Analysis of 2 Actimab-A Phase 1 clinical trials show that 42% of patients with low peripheral blast (PB) burden responded to Actimab-A while no patients with high PB burden responded to Actimab-AKey...
Actinium Further Str
Actinium Further Strengthens Clinical Development Team with Senior Hire to Support Later-Stage Clinical Trials
November 29, 2016 07:00 ET | Actinium Pharmaceuticals
NEW YORK, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Issues Lett
Actinium Issues Letter to Shareholders Highlighting 2016 Accomplishments and Anticipated Milestones for 2017
November 22, 2016 07:00 ET | Actinium Pharmaceuticals
NEW YORK, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for...
Actinium Pharmaceuti
Actinium Pharmaceuticals to Present at LD Micro Main Event Investor Conference
November 21, 2016 07:00 ET | Actinium Pharmaceuticals
NEW YORK, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...